Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-INHA Antibody (R2Z06)

Catalog #:   RHC13402 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IF, IHC
Accession: P05111
Overview

Catalog No.

RHC13402

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IF: 1:200-1:1000, IHC: 1:200-1:1000

Target

Inhibin alpha chain, INHA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P05111

Applications

IF, IHC

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R2Z06

Data Image
  • Immunofluorescence
    Confocal Immunofluorescence analysis of Hela cells using INHA mouse mAb (green). Red: Actin filaments have been labeled with DY-554 phalloidin. Blue: DRAQ5 fluorescent DNA dye.
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human lymphoid (A), ovary tumor (B) and testicle tumor (C) tissues using INHA mouse mAb with DAB staining.
References

Characterization of ex vivo expanded natural killer cells for cancer immunotherapy., PMID:40533418

Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinoma., PMID:40291702

Current and future perspectives in extensive-stage small-cell lung cancer., PMID:40093978

Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence., PMID:39990653

Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms., PMID:39966968

Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD., PMID:39932929

Phenotype of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in Children., PMID:39778568

MT-100, a human Tie2-agonistic antibody, improves penile neurovasculature in diabetic mice via the novel target Srpx2., PMID:39741183

Characteristics of glomerulonephritis with dominant C1q precipitation compared to corresponding glomerulonephritis without C1q staining on immunofluorescent examination., PMID:39639420

Clinical characteristics of toxoplasmosis patients in Korea: A retrospective study using health insurance review and assessment service data and electronic medical records., PMID:39622654

Synthesis of Silver Nanoparticles and Gold Nanoparticles Used as Biosensors for the Detection of Human Serum Albumin-Diagnosed Kidney Disease., PMID:39598335

Neuroprotective effect of L-DOPA-induced interleukin-13 on striatonigral degeneration in cerebral ischemia., PMID:39578419

Lecanemab: Appropriate Use Recommendations by Korean Dementia Association., PMID:39512702

Estimation of world seroprevalence of SARS-CoV-2 antibodies., PMID:39507207

Clinical Effectiveness of Biological Immunomodulators in SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children: A Systematic Review., PMID:39457145

Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies., PMID:39448393

Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors., PMID:39422843

PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders., PMID:39342430

High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy., PMID:39200906

Evaluation of NAD+ precursors for improved metabolism and productivity of antibody-producing CHO cell., PMID:39167557

Immunogenicity and Predictive Factors Associated with Poor Response after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Lung Transplant Patients., PMID:39066460

Immunotherapies for Childhood Cancer., PMID:39009446

Usefulness of the MFIS-K, FSS, and FACIT-F Fatigue Scales in Korean Patients With MS, NMOSD, and MOGAD., PMID:38951976

Multifunctional magnetic tags with photocatalytic and enzyme-mimicking properties for constructing a sensitive dual-readout ELISA., PMID:38908250

Targeted Therapies for EGFR Exon 20 Insertion Mutation in Non-Small-Cell Lung Cancer., PMID:38892105

Study on the value of Inhibin B in the diagnosis of nasopharyngeal carcinoma and its correlation with traditional Chinese medicine syndromes: An observational study., PMID:38847724

Protein loss during membrane processes in biopharmaceutical manufacturing., PMID:38719568

Advancements in Aptamer-Driven DNA Nanostructures for Precision Drug Delivery., PMID:38713753

CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis., PMID:38696731

Complementary Therapeutic Effect of Fecal Microbiota Transplantation in Ulcerative Colitis after the Response to Anti-Tumor Necrosis Factor Alpha Agent Was Lost: A Case Report., PMID:38672155

Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study., PMID:38664937

A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)., PMID:38497448

The Effect of Induction Therapy on Antibody-Mediated Rejection in Kidney Transplantation: A Network Meta-Analysis Using Recent Data., PMID:38490831

Evaluation of SARS-CoV-2 Vaccine-Induced Antibody Responses in Patients with Neuroimmunological Disorders: A Real-World Experience., PMID:38472974

High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction-Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation., PMID:38388292

Effect of Plasmapheresis on the Efficacy of Rituximab in Antibody-Mediated Rejection Patients., PMID:38383260

Effect of Induction Therapy Dose on Survival in Abo-Incompatible Kidney Transplantation: A Network Meta-Analysis Using Recent Data., PMID:38378338

Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation., PMID:38348341

Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation., PMID:38287890

Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines., PMID:38178704

Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study., PMID:38160001

Dielectrophoretic Capture of Cancer-Derived Small-Extracellular-Vesicle-Bound Janus Nanoparticles via Lectin-Glycan Interaction., PMID:38124514

Local Recurrent Melanoma Treated with BRAF and MEK Inhibitors Despite Adjuvant Anti-Programmed Cell Death Protein 1 Antibody Therapy., PMID:38061750

HMGB1 induces hepcidin upregulation in astrocytes and causes an acute iron surge and subsequent ferroptosis in the postischemic brain., PMID:37907744

Inflammation is responsible for systemic bone loss in patients with seropositive rheumatoid arthritis treated with rituximab., PMID:37867140

Prevalence, clinical significance, and persistence of autoantibodies in COVID-19., PMID:37845706

Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1., PMID:37783453

Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study., PMID:37761016

Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial., PMID:37711219

Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample., PMID:37591786

Datasheet

Document Download

Anti-INHA Antibody (R2Z06).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-INHA Antibody (R2Z06) [RHC13402]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only